Trial Profile
Phase I, Single Centre, Open Label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous AZD3043 After a Single Ascending Bolus Dose, and a Single Ascending Bolus Dose Followed by a Single Infusion Dose in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Oct 2015
Price :
$35
*
At a glance
- Drugs AZD 3043 (Primary)
- Indications Anaesthesia
- Focus Adverse reactions; First in man
- Sponsors AstraZeneca
- 14 Nov 2014 New trial record